Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERSONAL: PK Tailored Prophylaxis in Severe Haemophilia A
NCT02314325Phase 4Unknown
- Sponsor
- St James's Hospital
- Start
- Apr 2014
- Primary completion
- May 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of recombinant human coagulation factor VIII in hemophilia A (2 arms), sponsored by St James's Hospital. Primary endpoint: Number of subclinical haemarthroses at 18 months. Status: unknown.
02
Drugs
recombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT02314325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02314325.